Impact of cytogenetics in patients with relapsed or refractory multiple myeloma treated with bortezomib: Adverse effect of 1q21 gains
(Q84384168)
scientific article published on 26 May 2010
scientific article published on 26 May 2010
Language:
Current Data About
Impact of cytogenetics in patients with relapsed or refractory multiple myeloma treated with bortezomib: Adverse effect of 1q21 gains
other details
| description | scientific article published on 26 May 2010 |
External Links
| (P356) |
10.1016/J.LEUKRES.2010.05.002
|
| (P698) |
20537706
|